Dahl Andrew M. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Dahl Andrew M. has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $49K.

Profile

Andrew M. Dahl is the Senior Vice President and Corporate Controller at Edwards Lifesciences Corp, a leading company in medical devices for heart disease. He has been involved in the company's financial operations and reporting, contributing to its growth since its spinoff from Baxter International in 2000.

Board memberships

• Edwards Lifesciences Corp

Awards & honors

• Senior Vice President at Edwards Lifesciences
• Corporate Controller overseeing financial operations

Recent Transactions

Companies — Last 90 Days

• Edwards Lifesciences Corp (EW) — 2 filings, last 2026-05-29

Frequently Asked Questions

Who is Dahl Andrew M.?

Andrew M. Dahl is the Senior Vice President and Corporate Controller at Edwards Lifesciences Corp, a leading company in medical devices for heart disease. He has been involved in the company's financial operations and reporting, contributing to its growth since its spinoff from Baxter International in 2000.…

How many SEC Form 4 filings has Dahl Andrew M. submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Dahl Andrew M. been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($49K) across all tracked filings.

Where can I see all of Dahl Andrew M.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week